Home › Bronchopulmonary Dysplasia › NCT07896070
Impact of Higher Zinc Supplementation on Neonatal Weight Velocity
Who can join
25 Weeks – 34 Weeks · All sexes
Full eligibility criteria
Inclusion Criteria: * Birth weight: 750-1500 grams Exclusion Criteria: * Spontaneous Intestinal Perforation (SIP) * Necrotizing enterocolitis (NEC) * Gastrointestinal anomalies (gastroschisis, omphalocele, or intestinal atresia) * Infants on formula milk
About the study
Preterm infants born prematurely are more likely to have low zinc levels because they have less time to build up zinc before birth. They also have smaller zinc stores after birth and may need more zinc to support their rapid growth.
This study will examine how growth is affected in premature babies receiving either the current dose or a higher dose of zinc supplementation. The zinc supplement will be given daily, starting according to the unit's standard feeding guidelines, and will be stopped based on usual standard-of-care practices.
Possible risks of zinc supplementation include gastrointestinal intolerance (such as vomiting, diarrhea, or stomach discomfort) and anemia.
Possible benefits include improved growth, a stronger immune system, a shorter hospital stay, and lower healthcare costs.
What is being tested
- 1 mg/day Zinc Supplementation (drug)
- 3 mg/day Zinc Supplementation (drug)
Sponsor: Augusta University · Participants: 30 · Started: Aug 1, 2026
Contact the study team
- Julia Newman, DO · Phone: 706-721-2331
Official record on ClinicalTrials.gov — NCT07896070
Locations in the U.S.
| Georgia | Wellstar Childrens Hospital of Georgia, Augusta |
Conditions
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.